Form D · Other Technology
PAK BioSolutions, Inc.
Vienna, VA · CIK 0001781101
Offering snapshot reported Jun 26, 2024 · SEC filing
- Reported sold
- $5M Offering amount: $8.5M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 11, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 26, 2024 | Initial | $5,000,000 | No comparison | 2 | SEC filing |
| Jul 1, 2019 | Initial | $30,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-517021
Source: Form D, filed Jun 26, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Kevin Hill Byrne | Director, Executive |
| Pezzini Joanna | Executive |
| Daniel Kidle | Director |
| Joanna Pezzini | Director, Executive |
| Charles Purtell | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
8607 Westwood Center Drive, Suite 560
Vienna, VA, 22182
Vienna, VA, 22182